bupropion hydrobromide
Drug ingredientCAS 905818-69-1
This chemical is an active pharmaceutical ingredient used in FDA-regulated drugs.
US productionNot reported
Top sourceNo public record
This chemical is not on EPA’s Toxic Substances Control Act inventory, the list behind EPA’s production survey.
Why supply is unknownWhere It Comes From
EPA and Census publish no US supply data for this chemical.
7 FDA-registered drug labelers
Alivus Life Sciences Limited
Bausch Health US, LLC
Emnar Pharma Private Limited
HETERO DRUGS LIMITED
HIKAL LIMITED
Jubilant Biosys limited
Zhejiang Apeloa Jiayuan Pharmaceutical Co., Ltd.
Why It Matters
Sectors
Health
Downstream Uses
Appears in 1 drug and cosmetic product listings (FDA).
- •Aplenzin
FDA Shortage Status
Whether any manufacturer currently reports this drug as in shortage on the FDA Drug Shortages database. "Active Shortage" means at least one presentation has status "current."
No FDA shortage records
Chemical Identity
CAS905818-69-1
PubChem CID11984562
DTXSIDDTXSID20920317
FormulaC13H19BrClNO
Mol. Weight320.65 g/mol
SMILESCC(C(=O)C1=CC(=CC=C1)Cl)NC(C)(C)C.Br
Data Sources
- PubChem · compound 11984562Retrieved 2026-04-07
- FDA National Drug Code directoryRetrieved 2026-04-25
- FDA National Drug Code directoryRetrieved 2026-04-07
Brief citations
bupropion hydrobromide (CAS 905818-69-1) https://chemicalindependence.com/chemical/905818-69-1/ PubChem: 11984562. Retrieved 2026-04-07. https://pubchem.ncbi.nlm.nih.gov/compound/11984562 FDA National Drug Code directory: CAS 905818-69-1. Retrieved 2026-04-25. https://open.fda.gov/data/ndc/ FDA National Drug Code directory: bulk match. Retrieved 2026-04-07. https://open.fda.gov/data/ndc/